Reversal of Obesity- and Diet-Induced Insulin Resistance with Salicylates or Targeted Disruption of Ikkβ
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
We show that high doses of salicylates reverse hyperglycemia, hyperinsulinemia, and dyslipidemia in obese rodents by sensitizing insulin signaling. Activation or overexpression of the IκB kinase β (IKKβ) attenuated insulin signaling in cultured cells, whereas IKKβ inhibition reversed insulin resistance. Thus, IKKβ, rather than the cyclooxygenases, appears to be the relevant molecular target. Heterozygous deletion ( Ikkβ +/− ) protected against the development of insulin resistance during high-fat feeding and in obese Lep ob/ob mice. These findings implicate an inflammatory process in the pathogenesis of insulin resistance in obesity and type 2 diabetes mellitus and identify the IKKβ pathway as a target for insulin sensitization.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, inhibition or inactivation of JNK (18,26) or IKK (22,24,25,27) improves insulin sensitivity in various models of insulin resistance in association with reduced inhibitory serine phosphorylation of IRS-1 (18).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [22]
In the citing paper
“Along these lines, numerous insulin-resistant states (e.g., obesity, type 2 diabetes, and lipid/heparin infusion) are associated with increased activation of JNK (18,21) and/or IKK (21)(22)(23)(24)(25) in parallel with inhibitory serine phosphorylation of IRS-1 (18,21).”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [22]
In the citing paper
“Accordingly, KO or inhibition of JNK1 or IKKβ prevents insulin resistance in cell and mouse models (18,22,24,25,87) as well as human models (27) of insulin resistance.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [22]
In the citing paper
“JNK (18,21) and IKK (22,25) signaling are upregulated and activated in insulin-resistant human and rodent skeletal muscle.”
From Insulin sensitivity: Modulation by nutrients and inflammation (2008) · cites this paper as [22]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Festa, A., D’Agostino, R., Howard, G., Mykkänen, L., Tracy, R. P., & Haffner, S. M. (2000) · Circulation · doi:10.1161/01.cir.102.1.42 · Cited by 2,358
A cytokine-responsive IκB kinase that activates the transcription factor NF-κB
DiDonato, J. A., Hayakawa, M., Rothwarf, D. M., Zandi, E., & Karin, M. (1997) · Nature · doi:10.1038/41493 · Cited by 2,125
Self-citationZandi, E., Rothwarf, D. M., Delhase, M., Hayakawa, M., & Karin, M. (1997) · Cell · doi:10.1016/s0092-8674(00)80406-7 · Cited by 1,812
Self-citationInhibition of NF-κB by Sodium Salicylate and Aspirin
Kopp, E., & Ghosh, S. (1994) · Science · doi:10.1126/science.8052854 · Cited by 1,753
The anti-inflammatory agents aspirin and salicylate inhibit the activity of IκB kinase-β
Yin, M.-J., Yamamoto, Y., & Gaynor, R. B. (1998) · Nature · doi:10.1038/23948 · Cited by 1,590
Griffin, M. E., Marcucci, M. J., Cline, G. W., Bell, K., Barucci, N., Lee, D., Goodyear, L. J., Kraegen, E. W., White, M. F., & Shulman, G. I. (1999) · Diabetes · doi:10.2337/diabetes.48.6.1270 · Cited by 1,267
Is Type II diabetes mellitus a disease of the innate immune system?
Pickup, J. C., & Crook, M. A. (1998) · Diabetologia · doi:10.1007/s001250051058 · Cited by 1,041
Severe Liver Degeneration in Mice Lacking the IκB Kinase 2 Gene
Li, Q., Antwerp, D. V., Mercurio, F., Lee, K.-F., & Verma, I. M. (1999) · Science · doi:10.1126/science.284.5412.321 · Cited by 963
The IκB kinase (IKK) and NF-κB: key elements of proinflammatory signalling
Karin, M., & Delhase, M. (2000) · Seminars in Immunology · doi:10.1006/smim.2000.0210 · Cited by 955
Self-citation
Research works printed but not linked: 2
- Ebstein W., Berl. Klin. Wochnschr. 13, 337 (1876).
- Supplementary Web material is available on Science Online at www.sciencemag.org/cgi/content/full/293/5535/1673/DC1.
Cited by
Items 801–900 of 999
Gadang, V., Gilbert, W., Hettiararchchy, N. S., Horax, R., Katwa, L. C., & Devareddy, L. (2010) · Journal of Medicinal Food · doi:10.1089/jmf.2010.0010 · Cited by 57
Peroxisome proliferator-activated receptors: Bridging metabolic syndrome with molecular nutrition
Guri, A. J., Hontecillas, R., & Bassaganya-Riera, J. (2006) · Clinical Nutrition · doi:10.1016/j.clnu.2006.08.006 · Cited by 66
Beard, K. M., Lu, H., Ho, K., & Fantus, I. G. (2006) · Diabetes · doi:10.2337/db05-1538 · Cited by 64
Latent Inflammation and Insulin Resistance in Adipose Tissue
Stafeev, I. S., Vorotnikov, A. V., Ratner, E. I., Menshikov, M. Y., & Parfyonova, Y. V. (2017) · International Journal of Endocrinology · doi:10.1155/2017/5076732 · Cited by 57
“Substantiating the fundamental link between inflammation and insulin resistance, further research has discovered a role of IKK beta in the formation of insulin resistance [99].”
BackgroundSertoli cells for cell transplantation: pre‐clinical studies and future perspectives
Luca, G., Arato, I., Sorci, G., Cameron, D. F., Hansen, B. C., Baroni, T., Donato, R., White, D. J., & Calafiore, R. (2018) · Andrology · doi:10.1111/andr.12484 · Cited by 59
“…insulin sensitivity relates to alternatively activated macrophages (M2) through secretion of IL-4 and IL-10, whereas insulin resistance derives from proinflammatory macrophages (M1) secreting pro-inflammatory cytokines, such as TNFa (Yuan et al., 2001; Weisberg et al., 2003; Tateya et al., 2013).”
BackgroundMitochondrial factors in the pathogenesis of diabetes: a hypothesis for treatment.
Lamson, D. W., & Plaza, S. M. (2002) · PubMed · Cited by 70
Chapter 13 Phosphorylation of IRS Proteins
Sun, X., & Liu, F. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00613-4 · Cited by 71
Shi, X., Wang, X., Li, Q., Su, M. Y.-F., Chew, E. G. Y., Wong, E. T., Lacza, Z., Radda, G. K., Tergaonkar, V., & Han, W. (2013) · Diabetologia · doi:10.1007/s00125-013-2831-2 · Cited by 62
“For example, mice with brain- and hypothalamus-specific deletion of Ikkβ (also known as Ikbkb) show decreased food intake, and are protected against diet-induced obesity, insulin resistance and glucose intolerance [17–19].”
BackgroundMohorko, N., Petelin, A., Jurdana, M., Biolo, G., & Pražnikar, Z. J. (2015) · BioMed Research International · doi:10.1155/2015/418681 · Cited by 61
Marathe, C., Bradley, M. N., Hong, C., Chao, L., Wilpitz, D., Salazar, J., & Tontonoz, P. (2009) · Journal of Lipid Research · doi:10.1194/jlr.m800189-jlr200 · Cited by 56
Hepatic TRAF2 Regulates Glucose Metabolism Through Enhancing Glucagon Responses
Chen, Z., Sheng, L., Shen, H., Zhao, Y., Wang, S., Brink, R. A., & Rui, L. (2012) · Diabetes · doi:10.2337/db11-0474 · Cited by 58
Pathogenesis of Type 2 Diabetes
Stumvoll, M., Goldstein, B. J., & van Haeften, T. W. (2007) · Endocrine Research · doi:10.1080/07435800701743810 · Cited by 56
“ameliorate hyperglycemia and insulin resistance in diabetes and obesity (37,38).”
BackgroundGarcía‐Díaz, D. F., Campión, J., Milagro, F. I., Boqué, N., Moreno-Aliaga, M. J., & Martínez, J. A. (2010) · Journal of Molecular Endocrinology · doi:10.1677/jme-09-0160 · Cited by 59
“In addition, it has been reported that inflammatory-related pathways are activated in obesity and insulin resistance states (Yuan et al. 2001, Cai et al. 2005).”
BackgroundFratantonio, D., Cimino, F., Molonia, M. S., Ferrari, D., Saija, A., Virgili, F., & Speciale, A. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.12.008 · Cited by 58
Adropin deficiency worsens HFD-induced metabolic defects
Chen, S., Zeng, K., Liu, Q.-C., Guo, Z., Zhang, S., Chen, X.-R., Lin, J.-H., Wen, J.-P., Zhao, C.-F., Lin, X.-H., et al. (2017) · Cell Death & Disease · doi:10.1038/cddis.2017.362 · Cited by 56
Zhu, K.-L., Jiang, C., Tian, Y., Xiao, N., Wu, Z., L, Y., Lin, Z., Fang, S., Shang, X. L., Liu, K., et al. (2015) · Phytomedicine · doi:10.1016/j.phymed.2015.05.058 · Cited by 56
“Heterozygous knocked out (Ikkβ+/−) alleviated the341 development of insulin resistance in obese Lepob/ob and high-fat feed-342 ing mice (Yuan et al. 2001).”
BackgroundInsulin sensitizers may prevent metabolic inflammation
Colca, J. R. (2006) · Biochemical Pharmacology · doi:10.1016/j.bcp.2006.01.002 · Cited by 59
Stress, the Endoplasmic Reticulum, and Insulin Resistance
TSIOTRA, P. C., & TSIGOS, C. (2006) · Annals of the New York Academy of Sciences · doi:10.1196/annals.1367.007 · Cited by 56
Ectopic visceral fat: A clinical and molecular perspective on the cardiometabolic risk
Mathieu, P., Boulanger, M., & Després, J. (2014) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-014-9299-3 · Cited by 61
“Of interest, heterozygous IKKβ mice that are cross-bred with ob/ob mice have improved insulin sensitivity.[55] These data thus suggest a central role of the NF-κB in insulin signalling.”
BackgroundIleal interposition improves glucose tolerance and insulin sensitivity in the obese Zucker rat
Culnan, D. M., Albaugh, V. L., Sun, M., Lynch, C. J., Lang, C. H., & Cooney, R. N. (2010) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00525.2009 · Cited by 59
“In the ZR rat, obesity-related defects in muscle insulin signaling are reversed by anti-inflammatory therapies including salicylates and disruption of the I B kinase pathway (37).”
BackgroundObesity, adipogenesis and insulin resistance
Pérez, M. R., & Medina‐Gómez, G. (2011) · Endocrinología y Nutrición (English Edition) · doi:10.1016/j.endoen.2011.05.004 · Cited by 67
PPARβ/δ and lipid metabolism in the heart
Palomer, X., Barroso, E., Zarei, M., Botteri, G., & Vázquez‐Carrera, M. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2016.01.019 · Cited by 65
Shin, C. H., & Choi, D. (2019) · Cells · doi:10.3390/cells8020178 · Cited by 62
Vella, V., Lappano, R., Bonavita, E., Maggiolini, M., Clarke, R. B., Belfiore, A., & Francesco, E. M. D. (2023) · Endocrine Reviews · doi:10.1210/endrev/bnad005 · Cited by 62
Guo, C., Kogan, S., Amano, S. U., Wang, M., Dağdeviren, S., Friedline, R. H., Aouadi, M., Kim, J. K., & Czech, M. (2013) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00514.2012 · Cited by 57
“Importantly, it has been shown that decreasing inflammation with either genetic manipulation in rodents or pharmacological inhibition of key mediators of inflammation in humans (37, 50) improves insulin sensitivity.”
BackgroundPlasma Resistin Levels in Asthmatics as a Marker of Disease State
LaRochelle, J. S., Freiler, J. F., Dice, J. P., & Hagan, L. L. (2007) · Journal of Asthma · doi:10.1080/02770900701495785 · Cited by 54
Cheon, H., & Cho, Y. (2014) · Journal of Biomedical Science · doi:10.1186/1423-0127-21-13 · Cited by 54
“Hotamisligil GS, Peraldi P, Budavari A, Ellis R, White MF, Spiegelman BM: IRS-1-mediated inhibition of insulin receptor tyrosine kinase activity in TNF-alpha- and obesity-induced insulin resistance.”
BackgroundThe Immune Deficiency Pathway Regulates Metabolic Homeostasis in Drosophila
Davoodi, S., Galenza, A., Panteluk, A., Deshpande, R., Ferguson, M., Grewal, S., & Foley, E. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801632 · Cited by 56
Nutritional Modulation of Insulin Resistance
Weickert, M. O. (2012) · Scientifica · doi:10.6064/2012/424780 · Cited by 53
Role of renin–angiotensin–aldosterone system in adipose tissue dysfunction
Jing, F., Mogi, M., & Horiuchi, M. (2012) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2012.03.005 · Cited by 57
Hwang, D., Seo, S., Kim, Y., Kim, C., Shim, S., Jee, S., Lee, S., Jang, M., Kim, M.-S., Yim, S., et al. (2007) · Journal of Biosciences · doi:10.1007/s12038-007-0072-6 · Cited by 65
“It has been shown that obesity is associated with the activation of cellular stress signalling and the infl ammatory pathway (Hirosumi et al 2002; Ozcan et al 2004; Yuan et al 2001).”
Kelly, K. R., Kashyap, S. R., O’Leary, V. B., Major, J. A., Schauer, P. R., & Kirwan, J. P. (2009) · Obesity · doi:10.1038/oby.2009.328 · Cited by 51
“Our lack of association suggests that suppression of GLUT4 might be independent of adipose RBP4 expression and might be due to other factors such as macrophage migration into adipose tissue (17), or overproduction of macrophage-derived cytokines, which result in reduced GLUT4 protein (18).”
BackgroundIntegration of the metabolic and cardiovascular effects of exercise
Wagenmakers, A. J. M., van Riel, N. A. W., Frenneaux, M. P., & Stewart, P. M. (2006) · Essays in Biochemistry · doi:10.1042/bse0420193 · Cited by 51
A Randomized Trial of Low-Dose Aspirin in the Prevention of Clinical Type 2 Diabetes in Women
Pradhan, A. D., Cook, N. R., Manson, J. E., Ridker, P. M., & Buring, J. E. (2009) · Diabetes Care · doi:10.2337/dc08-1206 · Cited by 52
IKKβ Is Essential for Adipocyte Survival and Adaptive Adipose Remodeling in Obesity
Park, S., Liu, Z., Sui, Y., Helsley, R. N., Zhu, B., Powell, D. K., Kern, P. A., & Zhou, C. (2016) · Diabetes · doi:10.2337/db15-1156 · Cited by 54
Priyanka, A., Sindhu, G., Shyni, G. L., Rani, M., Nisha, V. M., & Raghu, K. (2016) · International Immunopharmacology · doi:10.1016/j.intimp.2016.11.019 · Cited by 55
“TLR4 is a major factor that drives the inflammatory NF-κB pathway [43] and JNK pathway [44].”
BackgroundNonalcoholic fatty liver disease and bariatric surgery: a comprehensive review
Cazzo, E., Pareja, J. C., & Chaim, É. A. (2017) · Sao Paulo Medical Journal · doi:10.1590/1516-3180.2016.0306311216 · Cited by 59
Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1
Park, S.-Y., Cho, Y.-R., Kim, H.-J., Hong, E.-G., Higashimori, T., Lee, S. J., Goldberg, I. J., Shulman, G. I., Najjar, S. M., & Kim, J. K. (2006) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00077.2006 · Cited by 51
“The molecular mechanism by which intracellular accumulation of fat causes insulin resistance involves activation of serine kinase cascade, of which PKC and/or I B kinase- may play a role, by fatty acid metabolites (i.e., fatty acyl-CoAs, diacylglycerol, ceramide), leading to the serine phosphorylation of insulin recep…”
BackgroundInfluentialPlant Hormones: Key Players in Gut Microbiota and Human Diseases?
Chanclud, E., & Lacombe, B. (2017) · Trends in Plant Science · doi:10.1016/j.tplants.2017.07.003 · Cited by 62
“However, these hormones also affect microbes and presumably would further perturb the imbalanced microbiota of diabetic patients [10,12].”
BackgroundGoldfine, A. B., Buck, J. S., Desouza, C. V., Fonseca, V. A., Chen, Y.-D. I., Shoelson, S. E., Jablonski, K. A., Creager, M. A., & for the TINSAL-FMD (Targeting Inflammation Using Salsalate in Type 2 Diabetes–Flow-Mediated Dilation) Ancillary Study Team (2013) · Diabetes Care · doi:10.2337/dc13-0859 · Cited by 51
Self-citationBeta cells in type 2 diabetes – a crucial contribution to pathogenesis
Maedler, K. (2007) · Diabetes Obesity and Metabolism · doi:10.1111/j.1463-1326.2007.00718.x · Cited by 64
Influence of Vitamin D Treatment on Transcriptional Regulation of Insulin-Sensitive Genes
Alkharfy, K. M., Al‐Daghri, N. M., Yakout, S. M., Hussain, T., Mohammed, A. K., & Krishnaswamy, S. (2013) · Metabolic Syndrome and Related Disorders · doi:10.1089/met.2012.0068 · Cited by 57
Hypertension in diabetes and the risk of cardiovascular disease
Sunkara, N. T., & Ahsan, C. H. (2017) · Cardiovascular Endocrinology · doi:10.1097/xce.0000000000000114 · Cited by 57
Drugs Involved in Dyslipidemia and Obesity Treatment: Focus on Adipose Tissue
Dias, S., Paredes, S., & Ribeiro, L. V. P. T. (2018) · International Journal of Endocrinology · doi:10.1155/2018/2637418 · Cited by 57
“TNFα activates TNF receptor (TNFR) which activates the inhibitor of NFκB kinase-B (IKKB) that in turn stimulates the NFκB pathway [15].”
BackgroundNonalcoholic fatty liver disease and the epidemic of obesity.
Collantes, R. S., Ong, J. P., & Younossi, Z. M. (2004) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.71.8.657 · Cited by 60
Li, J., Zhang, N., Ye, B., Ju, W., Orser, B. A., Fox, J. E. M., Wheeler, M. B., Wang, Q., & Lu, W. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707259 · Cited by 62
“Recent studies indicate that insulin resistance in diabetics results from hepatic activation of inhibitory kappa B kinase (IKK-b) and nuclear factor-kappa B (Yuan et al., 2001) and high doses of salicylates inhibit IKK-b activity and might therefore ameliorate insulin resistance and improve glucose tolerance in type I…”
BackgroundInfluentialZhao, M., Zhang, Z.-F., Ding, Y., Wang, J.-B., & Li, Y. (2012) · Molecules · doi:10.3390/molecules17067083 · Cited by 50
Schattenberg, J. M., & Schuchmann, M. (2009) · APOPTOSIS · doi:10.1007/s10495-009-0366-2 · Cited by 51
“The principal influence of NF-jB on the regulation of obesity was substantiated by the observation that the use of antiinflammatory drugs that inhibited IKK activity was blocking the development of insulin resistance in obese mice [83].”
Mechanisms of Disease: using genetically altered mice to study concepts of type 2 diabetes
LeRoith, D., & Accili, D. (2008) · Nature Clinical Practice Endocrinology & Metabolism · doi:10.1038/ncpendmet0729 · Cited by 52
“Ikbkb -knockout mice do not develop insulin resistance during a lipid infusion or when subjected to high-fat feeding”
BackgroundBech-Nielsen, G. V., Hansen, C. H. F., Hufeldt, M. R., Nielsen, D. S., Aasted, B., Vogensen, F. K., Midtvedt, T., & Hansen, A. K. (2011) · Research in Veterinary Science · doi:10.1016/j.rvsc.2011.04.005 · Cited by 56
“Additionally, neutralization of inflammatory mediators or depletion of key molecules in the activation of these have been shown to increase insulin sensitivity and glucose tolerance in animal models and humans (Hotamisligil et al., 1994; Hundal et al., 2002; Rakoff-Nahoum et al., 2004; Yuan et al., 2001).”
BackgroundHua, J., Ma, X., Webb, T. J., Potter, J. J., Oelke, M., & Li, Z. (2010) · Journal of Lipid Research · doi:10.1194/jlr.m003004 · Cited by 55
Self-citationCGI-58/ABHD5-Derived Signaling Lipids Regulate Systemic Inflammation and Insulin Action
Lord, C. C., Betters, J. L., Ivanova, P. T., Milne, S. B., Myers, D. S., Madenspacher, J., Thomas, G., Chung, S., Liu, M., Davis, M. A., et al. (2012) · Diabetes · doi:10.2337/db11-0994 · Cited by 45
“Of interest, the acute-phase response in the liver also is associated with transient overproduction of VLDL-TAG (34) and insulin resistance (24,25), two pathways that are stimulated by CGI-58 in vivo (2) (Figs.”
BackgroundSteinberg, G. R., Watt, M. J., Ernst, M., Birnbaum, M. J., Kemp, B. E., & Jørgensen, S. B. (2009) · Diabetes · doi:10.2337/db08-0659 · Cited by 49
“Both events activate inhibitory IRS-1 kinases such as I B kinase- (29,30), c-jun terminal amino kinase (28), and protein kinase C (31), which impair insulin signaling by inhibiting IRS-1 association with PI3-kinase subunits.”
BackgroundGillani, S. W., Sulaiman, S. A. S., Abdul, M. I. M., & Baig, M. R. (2017) · Cardiovascular Diabetology · doi:10.1186/s12933-017-0584-9 · Cited by 56
Nasoohi, S., Parveen, K., & Ishrat, T. (2018) · Journal of Alzheimer’s Disease · doi:10.3233/jad-180735 · Cited by 50
“:3) has been shown to improve insulin sensitivity [104].”
Metabolic and Molecular Mechanisms of Macrophage Polarisation and Adipose Tissue Insulin Resistance
Orliaguet, L., Ejlalmanesh, T., & Alzaïd, F. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21165731 · Cited by 58
“With numerous other studies demonstrating that blunting the inflammatory response, mitigates metabolic decline, preserves glycaemic homeostasis or even reverses insulin resistance (13-15)”
BackgroundPTP1B inhibitor Ertiprotafib is also a potent inhibitor of IκB kinase β (IKK-β)
Shrestha, S., Bhattarai, B. R., Cho, H., Choi, J., & Cho, H. (2007) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2007.03.001 · Cited by 51
Identification of intracellular peptides in rat adipose tissue: Insights into insulin resistance
Berti, D. A., Russo, L. C., Castro, L. M., Cruz, L., Gozzo, F. C., Heimann, J. C., Lima, F. B., de Oliveira, A. C., Andreotti, S., Prada, P. O., et al. (2012) · PROTEOMICS · doi:10.1002/pmic.201200051 · Cited by 51
“The latter observation was supported by the finding that insulin resistance could be induced in cellular models by overexpression of the IKK- signaling molecule, which is responsible for the activation of the inflammatory mediator NF B [5, 22, 23].”
BackgroundConstitutive Activation of IKKβ in Adipose Tissue Prevents Diet-Induced Obesity in Mice
Jiao, P., Feng, B., Ma, J., Nie, Y., Paul, E., Li, Y., & Xu, H. (2011) · Endocrinology · doi:10.1210/en.2011-1346 · Cited by 53
Bcl10 Links Saturated Fat Overnutrition with Hepatocellular NF-κB Activation and Insulin Resistance
Beek, M. V., Oravecz-Wilson, K. I., Delekta, P. C., Gu, S., Li, X., Jin, X., Apel, I. J., Konkle, K. S., Feng, Y., Teitelbaum, D. H., et al. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.04.006 · Cited by 51
“…studies suggest that FFA-induced NF-κB activation contributes to hepatic insulin resistance via inhibitory cross-talk within the hepatocyte, resulting in blockade of specific steps in downstream insulin signaling pathways (Arkan et al., 2005; Cai et al., 2005; Kim et al., 2001; Yuan et al., 2001).”
Decreasing CB1 receptor signaling in Kupffer cells improves insulin sensitivity in obese mice
Jourdan, T., Nicoloro, S. M. C., Zhou, Z., Shen, Y., Liu, J., Coffey, N. J., Çınar, R., Godlewski, G., Gao, B., Aouadi, M., et al. (2017) · Molecular Metabolism · doi:10.1016/j.molmet.2017.08.011 · Cited by 53
Pahlavani, M., Ramalho, T., Koboziev, I., LeMieux, M. J., Jayarathne, S., Ramalingam, L., Filgueiras, L. R., & Moustaid-Moussa, N. (2017) · Journal of Investigative Medicine · doi:10.1136/jim-2017-000535 · Cited by 49
Xie, Q., Gu, X., Chen, J., Liu, M., Xiong, F., Wu, X., Zhang, Y., Chen, F., Chen, H., Li, M., et al. (2018) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201800205 · Cited by 49
Cho, S. K., Huh, J. H., Yoo, J. S., Kim, J. W., & Lee, K. J. (2019) · Scientific Reports · doi:10.1038/s41598-019-51466-5 · Cited by 52
Inflammation, Atherosclerosis, and Aspects of Insulin Action
Bloomgarden, Z. T. (2005) · Diabetes Care · doi:10.2337/diacare.28.9.2312 · Cited by 52
Mechanism by which high-dose aspirin improves glucose metabolism in type 2 diabetes
Hundal, R. S., Petersen, K. F., Mayerson, A. B., Randhawa, P. S., Inzucchi, S. E., Shoelson, S. E., & Shulman, G. I. (2002) · Journal of Clinical Investigation · doi:10.1172/jci200214955 · Cited by 49
Self-citationAge-associated development of inflammation in Wistar rats: Effects of caloric restriction
Horrillo, D., Sierra, J., Arribas, C., García-San Frutos, M., Carrascosa, J. M., Lauzurica, N., Fernández-Agulló, T., & Ros, M. (2011) · Archives of Physiology and Biochemistry · doi:10.3109/13813455.2011.577435 · Cited by 45
“, 1993) or that the IKKβ/NF-κB signalling pathway is the target of salicylates were published (Shoelson et al., 2006; Yuan et al., 2001).”
BackgroundXu, Z., Yang, S., Tan, Y., Zhang, Q., Wang, H., Tao, J., Liu, Q., Wang, Q., Feng, W., Li, Z., et al. (2025) · Molecular and Cellular Biochemistry · doi:10.1007/s11010-025-05379-9 · Cited by 75
Self-citationTumor Progression Locus 2 (TPL2) Regulates Obesity-Associated Inflammation and Insulin Resistance
Perfield, J. W., Lee, Y., Shulman, G. I., Samuel, V. T., Jurczak, M. J., Chang, E., Xie, C., Tsichlis, P. N., Obin, M. S., & Greenberg, A. S. (2011) · Diabetes · doi:10.2337/db10-0715 · Cited by 53
“Accordingly, inflammatory signaling pathways have been targeted for the purposes of preventing or improving obesity-associated insulin resistance (3,9).”
BackgroundSun, X., Han, F., Yi, J., Han, L., & Wang, B. (2011) · Journal of Korean Medical Science · doi:10.3346/jkms.2011.26.6.765 · Cited by 49
“Recent studies indicated that aspirin might be an insulin-sensitizing agent and they may be used to reverse hyperglycemia, hyperinsulinemia, and dyslipidemia by sensitizing insulin signaling and improving insulin resistance (4).”
BackgroundInfluentialObesidad, adipogénesis y resistencia a la insulina
Pérez, M. R., & Medina‐Gómez, G. (2011) · Endocrinología y Nutrición · doi:10.1016/j.endonu.2011.05.008 · Cited by 91
Muscle Insulin Resistance and the Inflamed Microvasculature: Fire from Within
Liu, J., & Liu, Z. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030562 · Cited by 50
“investigated the temporal relationship between vascular insulin resistance and metabolic insulin resistance and the role of inflammation by assessing insulin responses in all arterial segments, including aorta, distal saphenous artery and the muscle microvasculature, as well as the metabolic insulin responses in rats…”
BackgroundInfluentialLin, L., Li, G., Zhang, W., Wang, Y., & Yang, H. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28533 · Cited by 52
Elinav, E., Pappo, O., Sklair‐Levy, M., Margalit, M., Shibolet, O., Gomori, M. J., Alper, R., Thalenfeld, B. E., Engelhardt, D., Rabbani, E., et al. (2005) · The Journal of Pathology · doi:10.1002/path.1869 · Cited by 49
Transcription Factor 7–like 2Polymorphism and Colon Cancer
Slattery, M. L., Folsom, A. R., Wolff, R. K., Herrick, J. S., Caan, B. J., & Potter, J. D. (2008) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-07-2687 · Cited by 50
“High doses of salicylates have been shown to reverse hyperglycemia, hyperinsulinemia, and dyslipidemia in obese rodents by improving sensitivity to insulin signaling (9).”
BackgroundHemi, R., Paz, K., Wertheim, N., Karasik, A., Zick, Y., & Kanety, H. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m109391200 · Cited by 49
Karagiannides, I., Stavrakis, D. G., Bakirtzi, K., Kokkotou, E. G., Pirtskhalava, T., Nayeb‐Hashemi, H., Bowe, C., Bugni, J. M., Nuño, M., Lu, B., et al. (2011) · Endocrinology · doi:10.1210/en.2010-1345 · Cited by 47
Yaspelkis, B. B., Kvasha, I. A., & Figueroa, T. Y. (2009) · American Journal of Physiology-Regulatory, Integrative and Comparative Physiology · doi:10.1152/ajpregu.00117.2009 · Cited by 47
Zhang, J., Wu, W., Li, D., Guo, Y., & Ding, H. (2009) · Endocrine · doi:10.1007/s12020-009-9283-y · Cited by 50
ER stress in adipocytes and insulin resistance: Mechanisms and significance (Review)
Khan, S. M., & WANG, C. H. (2014) · Molecular Medicine Reports · doi:10.3892/mmr.2014.2532 · Cited by 51
“Insulin-resistant states, including obesity and T2DM, are associated with the activation of JNK and/or IKK, which leads to serine phosphorylation of IRS1 and thus the induction of IR (35-39).”
Kuźmicki, M., Telejko, B., Wawrusiewicz‐Kurylonek, N., Lipińska, D., Pliszka, J., Wilk, J., Zielińska, A., Skibicka, J., Szamatowicz, J., Kretowski, A. J., et al. (2012) · European Journal of Endocrinology · doi:10.1530/eje-12-0654 · Cited by 49
Hosoi, T., Yamaguchi, R., Noji, K., Matsuo, S., Baba, S., Toyoda, K., Suezawa, T., Kayano, T., Tanaka, S., & Ozawa, K. (2014) · EMBO Molecular Medicine · doi:10.1002/emmm.201303227 · Cited by 48
“This result is consistent with the previous finding in which aspirin, an NSAID, had no anti-obesity effect (Yuan et al , 2001).”
Riera, C. E., & Dillin, A. G. (2015) · Nature Medicine · doi:10.1038/nm.4005 · Cited by 52
Zhong, J., Allen, K. M., Rao, X., Ying, Z., Braunstein, Z., Kankanala, S., Xia, C. Q., Wang, X., Bramble, L. A., Wagner, J. G., et al. (2016) · Inhalation Toxicology · doi:10.1080/08958378.2016.1179373 · Cited by 47
“Suppression of inflammation such as drug treatment or genetic disruption of pro-inflammatory gene may reverse obesity-induced insulin resistance (Hundal et al., 2002; Shoelson et al., 2003; Yuan et al., 2001).”
BackgroundLagraoui, M., Sukumar, G., Latoche, J. R., Maynard, S. K., Dalgard, C. L., & Schaefer, B. C. (2016) · Brain Behavior and Immunity · doi:10.1016/j.bbi.2016.12.005 · Cited by 49
“While considerable data suggest that the IKKbsuppressing anti-inflammatory activity of salsalate is responsible for the therapeutic benefit (Knudsen and Pedersen, 2015; Yuan et al., 2001), this interpretation may be too simplistic, as there are indications that salsalate-mediated AMPK activation is also critical for e…”
BackgroundFat, diabetes, and liver injury in chronic hepatitis C
Ratziu, V., Trabut, J., & Poynard, T. (2004) · Current Gastroenterology Reports · doi:10.1007/s11894-004-0022-5 · Cited by 51
Heitmeier, M. R., Kelly, C. B., Ensor, N. J., Gibson, K. A., Mullis, K. G., Corbett, J. A., & Maziasz, T. J. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m410978200 · Cited by 47
Matravadia, S., Herbst, E. A. F., Jain, S. S., Mutch, D. M., & Holloway, G. P. (2014) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00032.2014 · Cited by 46
“Therefore, the increase in ETC subunits following ALA supplementation may be construed as a negative adaptation, as mitochondrial lipid uptake and ROS emission have been causally linked to IR (2), possibly through ROS-mediated activation of the NF- B/ I B/IKK pathway, attenuating insulin signaling by serine phosphoryl…”
BackgroundThouvenot, K., Turpin, T., Taïlé, J., Clément, K., Meilhac, O., & Gonthier, M. (2022) · Biomolecules · doi:10.3390/biom12030378 · Cited by 57
Chapter 12 Serine Kinases of Insulin Receptor Substrate Proteins
Boura‐Halfon, S., & Zick, Y. (2009) · Vitamins and hormones · doi:10.1016/s0083-6729(08)00612-2 · Cited by 58
“In contrast, selective loss of IKKb in hepatocytes retains insulin sensitivity in liver but not in muscle or fat tissues in response to HFD (Yuan et al., 2001).”
BackgroundInfluentialChai, W., Liu, J., Jahn, L. A., Fowler, D. E., Barrett, E. J., & Liu, Z. (2011) · Diabetes Care · doi:10.2337/dc10-2345 · Cited by 46
“This is clinically significant because treatment with either aspirin or salsalate improves insulin resistance and glycemic control in animals (4,11,12), and clinical trials also have shown promising results.”
BackgroundDharmadhikari, G., Stolz, K., Hauke, M., Morgan, N. G., Varki, A. P., de Koning, E. J. P., Kelm, S., & Maedler, K. (2017) · Scientific Reports · doi:10.1038/srep45319 · Cited by 48
Tatebe, S., Sinicrope, F. A., & Kuo, M. T. (2002) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.2002.6367 · Cited by 51
Sugiyama, H., Yoshida, M., Mori, K., Kawamoto, T., Sogabe, S., Takagi, T., Oki, H., Tanaka, T., Kimura, H., & Ikeura, Y. (2007) · Chemical and Pharmaceutical Bulletin · doi:10.1248/cpb.55.613 · Cited by 47
Triglyceride and glucose (TyG) index is an effective biomarker to identify severe acute pancreatitis
Park, J. M., Shin, S. P., Cho, S. K., Lee, J. H., Kim, J. W., Kang, C. D., Huh, J. H., & Lee, K. J. (2020) · Pancreatology · doi:10.1016/j.pan.2020.09.018 · Cited by 48
Self-citationCalcaterra, V., Verduci, E., Vandoni, M., Rossi, V., Fiore, G., Massini, G., Berardo, C., Gatti, A., Baldassarre, P., Bianchi, A., et al. (2022) · Nutrients · doi:10.3390/nu14214692 · Cited by 64
“It has been observed through studies on mouse models that the genetic inactivation of these two pathways improves insulin resistance [35,37–39], a result also confirmed by pharmacological inhibition of the NF-κB pathway with high doses of salicylates or aspirin [37,40].”
BackgroundWang, M., Gao, X., Zhao, W., Zhao, W., Jiang, C., Huang, F., Kou, J., Liu, B. L., & Liu, K. (2013) · British Journal of Pharmacology · doi:10.1111/bph.12276 · Cited by 45
“Salicylate reduces insulin resistance both by inhibition of IκB kinase β (IKKβ; Yuan et al., 2001) and activation of AMPK, induced by inhibiting the dephosphorylation of p-AMPK (Hawley et al., 2012).”
BackgroundYu, Z., Li, D., Ling, W.-H., & Jin, T. (2012) · World Journal of Diabetes · doi:10.4239/wjd.v3.i1.19 · Cited by 48
Jang, E.-H., Ko, J. H., Ahn, C.-W., Lee, H.-H., Shin, J.-K., Chang, S.-J., Park, C., & Kang, J. (2010) · Life Sciences · doi:10.1016/j.lfs.2009.12.012 · Cited by 51
Bakar, M. H. A., Sarmidi, M. R., Tan, J. S., & Rosdi, M. N. M. (2017) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2017.01.043 · Cited by 46
“…on the considerations that the specific whole body NF-κB inhibition through pharmacological means or by heterozygous deletion of the NF-κB-activating kinase IKK-2 exhibited protective mechanism against lipid infusion-induced insulin resistance and obesity (Kim et al., 2001; Yuan et al., 2001).”
Background
Metadata
- Authors
- Yuan, M., Konstantopoulos, N., Lee, J., Hansen, L., Li, Z.-W., Karin, M., & Shoelson, S. E.
- Affiliations
- Joslin Diabetes Center (US)
- Department of Pharmacology, University of California, San Diego, La Jolla, CA 92093, USA.
- University of California San Diego (US)
- Corresponding author
- Yuan, Minsheng
- Konstantopoulos, Nicky
- Lee, Jongsoon
- Shoelson, Steven E.
- Venue
- Science
- Published
- 2001-08-31
- Volume
- 293
- Issue
- 5535
- Pages
- 1673-1677
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2031637294
- Cited by
- 1,884
- References
- 26
- Citations by year
- 2026: 16 · 2025: 29 · 2024: 27 · 2023: 36 · 2022: 41 · 2021: 51 · 2020: 51 · 2019: 61 · 2018: 54 · 2017: 70 · 2016: 78 · 2015: 93 · 2014: 109 · 2013: 124 · 2012: 99
- FWCI
- 56.75
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Institutes of Health (5r29dk045493-05)
- National Institute of Allergy and Infectious Diseases (AI 43477)
- National Institute of Diabetes and Digestive and Kidney Diseases (DK 51729, DK45493)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › NF-κB Signaling Pathways
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Keywords
- insulin resistance, obesity, salicylates, IκB kinase β, insulin signaling, inflammation, type 2 diabetes, hyperinsulinemia, hyperglycemia, dyslipidemia, high-fat diet, ob/ob mice, insulin sensitization, cyclooxygenase
- MeSH terms
- Animals, Anti-Inflammatory Agents, Non-Steroidal, Aspirin, Blood Glucose, Cell Line, Dietary Fats, Glucose Tolerance Test, Insulin, Insulin Resistance, Lipids, Liver, Male, Mice, Obese, Muscles, Obesity, Phosphorylation, Prostaglandin-Endoperoxide Synthases, Rats, Zucker, Receptor, Insulin, Sodium Salicylate, Tumor Necrosis Factor-alpha, Signal Transduction, Protein Serine-Threonine Kinases, Gene Deletion, Gene Targeting, Mice, Rats, I-kappa B Kinase
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.